J&J Switches Benacort Hayfever Spray From Rx To GSL Status In The UK
J&J switches its Benacort hayfever nasal spray from prescription-only to general sales list status in the UK, making it the third mass market steriod-based spray available outside pharmacy.
You may also be interested in...
Sanofi has switched its Allevia hay fever tablets (fexofenadine hydrochloride) in the UK, from prescription-only to general sales list status.
Johnson & Johnson believes personalization via digital holds the key to smoking cessation success as it launches in the UK its app-supported Nicorette QuickMist SmartTrack product.
While J&J benefits from “underlying strength” of its large skin care brands, it targets “regular additions of local, smaller brands,’ says global consumer business head Thibaut Mongon. Portfolio balance of international and localized brands helps it weather economic uncertainty during the COVID-19 pandemic.